Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis-Reference-Cited by-同舟云学术

Autologous hematopoietic stem cell transplantation with reduced-intensity conditioning in multiple sclerosis

Published:2012-11 Issue:11 Volume:40 Page:892-898
ISSN:0301-472X
Container-title:Experimental Hematology
language:en
Short-container-title:Experimental Hematology

Author:

Shevchenko Jury L.,Kuznetsov Alexey N.,Ionova Tatyana I.,Melnichenko Vladimir Y.,Fedorenko Denis A.,Kartashov Andrei V.,Kurbatova Kira A.,Gorodokin Gary I.,Novik Andrei A.

Publisher

Elsevier BV

Subject

Cancer Research,Cell Biology,Genetics,Hematology,Molecular Biology

Reference36 articles.

1. The natural history of multiple sclerosis;Weinshenker;Neurol Clin,1995

2. The natural history of multiple sclerosis: a geographically based study. I. Clinical course and disability;Weinshenker;Brain,1989

3. McAlpine’s Multiple Sclerosis;Compston,1998

4. Multiple sclerosis;Hafler;J. Clin Invest,2004

5. Therapy;Kappos,1997

Cited by 54 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Autologous Hematopoietic Stem Cell Transplantation to Treat Multiple Sclerosis;Neurologic Clinics;2024-02

2. Second Autologous Hematopoietic Stem Cell Transplantation in Multiple Sclerosis: A Single-Center Prospective Experience;Transplantation Proceedings;2024-01

3. The HSCT procedure (II): Conditioning, hematopoietic stem cell infusion, supportive care, and monitoring;Handbook of Clinical Neurology;2024

4. Using immature platelet fraction as a factor in deciding on the need for platelet transfusions;Pediatric Hematology/Oncology and Immunopathology;2023-10-01

5. Is Autologous Hematopoietic Stem Cell Transplant Better Than High-Efficacy Disease-Modifying Therapies for Relapsing Multiple Sclerosis?;JAMA Neurology;2023-07-01